With increasing evidence that LRP6 is closely associated with tumor development and progression, various antibodies [21], peptides [16], and small molecules [22] have been developed and show anticancer properties by inhibiting LRP6 function directly or indirectly. Here, LRP6 is linked to neoplasm.